Phase II

Type: Keyphrase
Name: Phase II
First reported 1 hour ago - Updated 1 hour ago - 1 reports

Updates Posted on CAF Phase II Map, Rural Broadband Experiments

The FCC has updated its Connect America Fund (CAF) Phase II map of initial eligible areas in an effort to assist parties participating in the CAF Phase II challenge process and/or investigating potential areas for Rural Broadband Experiments.  The map ... [Published Bennet & Bennet - 1 hour ago]
First reported 12 hours ago - Updated 2 hours ago - 2 reports

Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014

SOURCE Isis Pharmaceuticals, Inc.KYNAMRO®, ISIS-APOCIIIRX AND ISIS-APO(A)RX DATA PRESENTEDCARLSBAD, Calif.In two invited presentations, Dr. John Kastelein"The statistical significant decrease in rate of MACE in patients treated with KYNAMRO represents ... [Published WLBT - 12 hours ago]
First reported 10 hours ago - Updated 3 hours ago - 3 reports

Kaminak Drills New Gold Discovery 3.55gt Au over 28m at Coffee and Announces Phase II Exploration Program

Hispanic Business Magazine Tuesday 2nd September, 2014. The objective of the program was to drill test priority gold-in-soil anomalies situated proximal to the current resource that have the potential to contribute high-value, open-pit oxide resources ... [Published Canada Standard - 3 hours ago]
First reported 6 hours ago - Updated 6 hours ago - 1 reports

Town releases public input report

Nearly 200 residents attended the public input meeting on Aug. 27 and shared ideas about the future recreation development of 245 acres of land on Rifle Range Road and Phase 2 of Memorial Waterfront Park. Below are lists of the top five choices in each ... [Published Berkeley Independent - 6 hours ago]
Entities: Phase II, BMX Cycling, Sport
First reported 7 hours ago - Updated 6 hours ago - 5 reports

HLM’s Phase II Drilling Confirms and Extends High-Grade Lithium Zone at Surface on the PAK Rare Metals Project, Ontario

SUDBURY, Ontario--(BUSINESS WIRE)--Houston Lake Mining Inc. (TSX.V:HLM) Highlights:Diamond Drill Hole (DDH) PL-011-14 intersected 1.68% Li2O over 104 metre (m) from 9.1m to 104.75 m;DDH PL-011-14 includes a 12.8 m wide high-grade lithium zone (Upper Intermediate ... [Published Investor's Business Daily - 6 hours ago]
First reported 11 hours ago - Updated 7 hours ago - 2 reports

Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th

SAN DIEGOInterested parties can access a live audio webcast and slide presentation on the Mast Therapeutics web site at www.masttherapeutics.com. An archived presentation will be available on the web site for 30 days.About Mast TherapeuticsMast Therapeutics, ... [Published Bio-Medicine - 7 hours ago]
First reported 11 hours ago - Updated 7 hours ago - 2 reports

VentiRx gets FDA fast track status for motolimod to treat ovarian cancer

VentiRx Pharmaceuticals has received fast track designation from the US Food and Drug Administration (FDA) for the investigation of motolimod (VTX-2337) when administered in combination with pegylated liposomal doxorubicin (PLD) to treat women with ovarian ... [Published Pharmaceutical Business Review - 7 hours ago]
First reported 9 hours ago - Updated 9 hours ago - 2 reports

MEI Pharma completes patient enrollment in Pracinostat Phase II trial for treatment of MDS

MEI Pharma, Inc., an oncology company focused on the clinical development of novel therapies for cancer, announced today that it has completed enrollment in a randomized Phase II clinical trial of its lead investigational drug candidate Pracinostat i ... [Published BioPortfolio - 9 hours ago]
First reported 10 hours ago - Updated 10 hours ago - 2 reports

MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome

MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that it has completed enrollment in a randomized Phase II clinical trial of its lead investigational drug candidate ... [Published Benzinga.com - 10 hours ago]
First reported 11 hours ago - Updated 10 hours ago - 2 reports

Update: VCXC Launches HDN Phase II as Further Demonstration of HD Voice Interoperability

Voice Communication Exchange Committee (VCXC) launches the HDN Phase II Trial demonstrating HD voice provisioning through the Number Portability Administration Center (NPAC) operated by Neustar. The HDN provides a mechanism…Click to Continue » ... [Published Fort Mills Times - 10 hours ago]
First reported 16 hours ago - Updated 14 hours ago - 3 reports

ReNeuron : Says Core Therapeutic Programme On Track

LONDON ( Alliance News ) - ReNeuron Group PLC said Tuesday that its core therapeutic programme remains on track toward achieving clinical milestones over the next 18 months as the company continues to search for a new Chief Executive Officer.In a trading ... [Published 4 Traders - 14 hours ago]
First reported 23 hours ago - Updated 23 hours ago - 1 reports

Planning application lodged for Phase 2 of Centre Severn, Gloucester

Peveril Securities has submitted a planning application to Gloucester City Council for the second phase of development at Centre Severn, an established and successful leisure destination adjacent to Barnwood Fields Business Park on the A40 between Gloucester ... [Published Commercial News Media - 23 hours ago]

Quotes

"We are pleased with the designation of orphan drug status for the active moiety of APD811, and we look forward to advancing this drug candidate into a Phase 2 clinical trial program later this year" said Craig Audet, Arena's senior vice president of pperations and head of global regulatory affairs
"Because we didn't know how much Bismarck would grow and how quickly, our board built Lincoln and Liberty so we can expand each school by four classrooms, which is about 100 students each,” Uselman said."
...advancing PRM-151 to better meet the needs of patients with myelofibrosis," said Suzanne Bruhn, president and chief executive officer of Promedior. "Based on the encouraging clinical results reported to date in myelofibrosis patients we believe that PRM-151’s novel mechanism of action is compelling with its potential to target and reverse the fundamental bone marrow fibrosis that underlies patients’ disease."
...The organization's vision: "Empowering otolaryngologist-head and neck surgeons to deliver the best patient care."

More Content

All (7369) | News (5721) | Reports (3) | Blogs (1441) | Audio/Video (0) | Fact Sheets (27) | Press Releases (141)
sort by: Date | Relevance
County approves Victory Pipeline [Published Vernal Express - 17 mins ago]
Ocular Therapeutix announces Q2 financial results [Published Orthopedics Today - 19 mins ago]
Ski area improvements at Colorado Ski Country U... [Published Examiner.com - 25 mins ago]
Acura Pharmaceuticals awarded $300,000 grant to... [Published Drug Store News - 34 mins ago]
Arena Pharmaceuticals' Drug Candidate Granted O... [Published San Diego Business Journal - 49 mins ago]
Gusman responds to City Council resolution on P... [Published Louisiana Weekly - 53 mins ago]
Enrollment continues to increase at Bismarck sc... [Published Bismarck Tribune - 55 mins ago]
FDA Names Myelofibrosis Treatment an Orphan Drug [Published Drug Discovery and Development - 1 hour ago]
Latest ear, nose, throat, head and neck researc... [Published EurekAlert! - 1 hour ago]
Diabetes biotech Viking Therapeutics sets terms... [Published Nasdaq - 1 hour ago]
An ambitious housing plan for homeless Ilonggos [Published Panay News - 1 hour ago]
Updates Posted on CAF Phase II Map, Rural Broad... [Published Bennet & Bennet - 1 hour ago]
Daily Decision Service Alert: Vol. 23, No. 163 ... [Published New Jersey Law Journal - 1 hour ago]
Bayer/Johnson & Johnson to Expand Xarelto Label... [Published Zacks.com - 1 hour ago]
Phl to woo BPM, manufacturing companies from U... [Published Philippine Star - 1 hour ago]
New ASCO Guideline for HER2-negative Advanced B... [Published Diabetes Care - 1 hour ago]
FDA Fast-Tracks Pfizer's C Difficile Vaccine [Published Pharmacy Times - 1 hour ago]
Mercom Revises India Solar Installation Forecas... [Published Global Solar Technology - 1 hour ago]
Commerce RI, Office of Energy Resources and Ene... [Published Review Zone - 1 hour ago]
Janssen expands Xarelto research program [Published Orthopedics Today - 1 hour ago]
OpportunityAnalyzer: Non-Hodgkin's B-Cell -2- [Published Scottrade - 2 hours ago]
Big Java news in late summer 2014 [Published Java World - 2 hours ago]
Aerpio Therapeutics Announces Publication of Pr... [Published Scottrade - 2 hours ago]
Prostate cancer biotech Tokai Pharmaceuticals s... [Published Renaissance Capital - 2 hours ago]
Scientists' Work May Lead to Mission to Find O... [Published Newswise - 2 hours ago]
Reminder: IFIT funding deadline approaches [Published Pulp & Paper Canada - 2 hours ago]
Merck And Advaxis Partner In Prostate Immunothe... [Published Bioresearch Online - 3 hours ago]
EC Designates Innate’s CTCL Antibody As Orphan ... [Published Bioresearch Online - 3 hours ago]
Five things for pharma marketers to know: Tuesd... [Published Medical Marketing And Media - 3 hours ago]
Crimson Cafe opens after ribbon cutting ceremony [Published Indiana University Penn - 3 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Somalia: Over one million people in Somalia fac... [Published ReliefWeb - Latest Updates - 3 hours ago]
Source: Famine Early Warning System Network, Food Security and Nutrition Analysis UnitCountry: Somalia September 2, 2014, Nairobi/Washington – The gradual recovery and gains made since the end of the famine in 2012 are being lost as poor rains, conflict, ...
BioNews [9.2.14] [Published eClinical Trends - 6 hours ago]
Top News HeadlineCompanyType Exelixis, Inc. Chops 70 Percent Of Workforce After Prostate Drug Cabozantinib Fails Pivotal Study Exelixis, Inc.Jobs Acadia surges after nabbing 'breakthrough' title for late-stage Parkinson's drug Acadia ...
HLM’s Phase II Drilling Confirms and Extends Hi... [Published Business Wire Natural Resources News - 7 hours ago]
SUDBURY, Ontario--(BUSINESS WIRE)--Houston Lake Mining Inc. (TSX.V:HLM) Highlights: Diamond Drill Hole (DDH) PL-011-14 intersected 1.68% Li2O over 104 metre (m) from 9.1m to 104.75 m; DDH PL-011-14 includes a 12.8 m wide high-grade lithium zone (Upper ...
Burundi: Burundi Remote Monitoring Update - Aug... [Published ReliefWeb - Latest Updates - 7 hours ago]
Source: Famine Early Warning System NetworkCountry: Burundi Above-average food prices limit household food access in the Northeast KEY MESSAGES • Land preparation is underway in most zones across the country. This is seasonably providing labor ...
Somalia: Key Findings from the 2014 Post Gu Sea... [Published ReliefWeb - Latest Updates - 7 hours ago]
Source: Famine Early Warning System Network, Food Security and Nutrition Analysis UnitCountry: Somalia SUMMARY RESULTS Gradual recovery and gains made since the end of the famine in 2012 are being lost Over 1 million people are acutely food insecure ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Conatus Pharmaceuticals Initiates Phase 2 Trial... [Published GlobeNewswire: Advertising News - 12 hours ago]
Ormat Completes Financing for McGinness Hills P... [Published GlobeNewswire: Acquisitions News - Aug 29 2014]
Telik Receives $1.5 Million National Cancer Ins... [Published Financial Services - Aug 25 2014]
Karolinska Development AB (publ) – Interim Repo... [Published GlobeNewswire: Acquisitions News - Aug 21 2014]
Celator(R) Pharmaceuticals Initiates Pharmacoki... [Published GlobeNewswire: Acquisitions News - Aug 19 2014]
1 2 3 4 5 6 7 8 9 10 ...
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.